The new Somnibel positional device is available on sale now. It provides an innovative treatment for sleep apnea and positional snoring.

Somnibel is born from the need of a patient with positional OSA and from his collaboration with SIBELMED and BIOEF. It has been developed by SIBELMED with the cooperation of the sleep units of the Araba University Hospital / Osakidetza and the Arnau de Vilanova University Hospital of Lleida.

Somnibel is a Class IIa medical device protected by several international patents, which reduces the incidence of sleep apnea and / or positional snoring. It consists of a small and light device attached to the forehead that applies a soft vibration while the patient sleeps supine to induce him to change position, thus reducing the incidence of sleep breathing events, whether apneas or positional snoring.

It allows:
• Reduce the number of apneas (Apnea-hypopnea Index)
• Improve blood oxygen saturation
• Improve the quality of sleep and daytime sleepiness
• Improve arterial hypertension
• Improve Life Quality
• Improve the couple’s rest

Somnibel is available in 2 different models:
• Somnibel for patient use.
• Somnibel Pro for professional use in sleep units and prescribing centers.

Somnibel has been validated through a clinical trial in 128 patients conducted in two independent sleep units of international prestige and the results confirm that it is an effective system in the reduction of sleep apnea. It is safe, well tolerated and does not produce relevant side effects. This device could be used as a single treatment and / or in combination with other treatments in patients with positional OSA.

Somnibel can be purchased by contacting SIBELMED:

export@sibelmed.com

+34 93 436 00 07 or web: www.somnibel.eu